UPenn Shield
NEUROETHICS Header

HOME

Overview

Brain Imaging

Pharmacological Enhancement of Cognition

Pharmacological Enhancement of Mood and Related Functions

Responsibility and Brain Function

Brains, Minds and Souls

The Consciousness Continuum

Narrative Perspectives

Events Calendar

Course Syllabi

Relevant Websites


PENN NEUROETHICS PROGRAM

Pharmacological Enhancement of Cognition

Many neuropsychiatric illnesses occur on a spectrum that includes normal levels of functioning. This raises the question: if medications can improve cognition in people with cognitive impairment, what can they do for normal healthy people?

Two main cognitive systems have been targeted for pharmacological enhancement: attention and memory. Stimulant drugs such as methyphenidate (Ritalin) and amphetamine (Aderall) improve the attention

British Medical Association. (2007). Ethics department: Boosting your brainpower: ethical aspects of cognitive enhancements.

Chatterjee, A. (2004). Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology, 63 (6): 968-974.

* Chamberlain, S.R., Muller, U., Robbins, T.W. & Sahakian, B.J. (2006). Neuropharmacological modulation of cognition. Current Opinion in Neurology, 19: 607-612.

Diller, L.H. (1996). The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Hastings Center Report, 26: 12-18.

Farah, M. J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., Parens, E., Sahakian, B. J., and Wolpe, P. R. (2004). Neurocognitive enhancement: What can we do? What should we do? Nature Reviews Neuroscience, 5: 421-425.

Farah, M.J. and Wolpe, P.R. (2004). Monitoring and manipulating brain function: New neuroscience technologies and their ethical implications. Hastings Center Report, 34(3): 35-45.

Flower, R. (2004). Lifestyle drugs: pharmacology and the social agenda. Trends in Pharmacological Sciences, 25:182-185.

Fukuyama, F. (2002). Our Posthuman Future. Farrar, Strauss and Giroux.

Glannon, W. (2006). Psychopharmacology and memory. Journal of Medical Ethics, (32): 74-78.

Hall, S.S. (2003). The quest for a smart pill. Scientific American, September: 54-65.

Kass, L. (2003). Beyond Therapy: Biotechnology and the Pursuit of Happiness. Harper Collins.

Kolber, A.J. (2006). Therapeutic forgetting: the legal and ethical implications of memory dampening. Vanderbilt Law Review, 59 (5): 1559-1615.

*Lynch, G.  (2004).  AMPA receptor modulators as cognitive enhancers.  Current Opinion in Pharmacology, 4: 4-11.

Makris, A.P., Rush, C.R. Frederich, R.C., Taylor, A.C. & Kelly, T.H. (2007). Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Experimental Clinical Psychopharmacology, 15 (2): 123-133.

McCabe, S.E. et al. (2005).  Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.  Addiction, 99: 96-106.

Mehlman, M.J.  (2004). Cognition-enhancing drugs.  The Milbank Quarterly, 82: 483-506.

* Mehta, M. A., Owen, A. M., et al. (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience, 20: RC65.

* O'Leary JC. (1993). An analysis of the legal issue surrounding the forced use of Ritalin: protecting a child's right to "just say no. New England Law Review, 27: 1173-209.

Parens, E. (Ed.) (2000). Enhancing Human Traits: Social and Ethical Implications. Georgetown University Press.

* Pitman, R. K., Sanders, K.M., Zusman, R.M., Healy, A.R., Cheema, F., and Lasko, N.B. (2002). Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biological Psychiatry, 15: 189-192.

Rose, S.P.R. (2002). "Smart Drugs": Do they work? Are they ethical? Will they be legal? Nature Reviews Neuroscience, 3: 975-979.

Sahakian, B. & Morein-Zamir, S. (2007). Professor's little helper. Nature, 450: 1157-1159.

Singh, I. (2005). Will the "Real Boy" Please Behave: Dosing Dilemmas for Parents of Boys with ADHD. The American Journal of Bioethics, 5(3): 34-47.

Turner, D. and Sahakian, B. (2006). The cognition enhanced classroom. In P. Miller & J. Wilsdon Better Humans? The politics of human enhancement and life extension. London: Demos, p. 79-85.

Wheelis, M. and Dando, M. (2005). Neurobiology: a case study of the imminent militarization of biology. International Review of the Red Cross, 87(859): 553-571.

Wilson, J.S. (2004). Mediums and Messages: an Argument AGainst Biotechnical Enhancements of Soldiers in the Armies of Liberal Democracies. Ethical Perspectives, 11(2-3): 189-197.